Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 25


Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study.

Cane P, Chrystie I, Dunn D, Evans B, Geretti AM, Green H, Phillips A, Pillay D, Porter K, Pozniak A, Sabin C, Smit E, Weber J, Zuckerman M; UK Group on Transmitted HIV Drug Resistance.

BMJ. 2005 Dec 10;331(7529):1368. Epub 2005 Nov 18.


Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

Masquelier B, Bhaskaran K, Pillay D, Gifford R, Balestre E, Jørgensen LB, Pedersen C, van der Hoek L, Prins M, Balotta C, Longo B, Kücherer C, Poggensee G, Ortiz M, de Mendoza C, Gill J, Fleury H, Porter K; CASCADE Collaboration.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):505-11.


Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom.

Pillay D, Green H, Matthias R, Dunn D, Phillips A, Sabin C, Evans B; UK Collaborative Group on HIV Drug Resistance.

J Infect Dis. 2005 Sep 15;192(6):967-73. Epub 2005 Aug 12.


Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

Zaccarelli M, Tozzi V, Lorenzini P, Trotta MP, Forbici F, Visco-Comandini U, Gori C, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of HIV Genotype Resistance Test (GRT) at National Institute for Infectious Diseases Lazzaro Spallanzani.

AIDS. 2005 Jul 1;19(10):1081-9.


French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.

Descamps D, Chaix ML, André P, Brodard V, Cottalorda J, Deveau C, Harzic M, Ingrand D, Izopet J, Kohli E, Masquelier B, Mouajjah S, Palmer P, Pellegrin I, Plantier JC, Poggi C, Rogez S, Ruffault A, Schneider V, Signori-Schmück A, Tamalet C, Wirden M, Rouzioux C, Brun-Vezinet F, Meyer L, Costagliola D.

J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):545-52.


Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice.

Phillips AN, Dunn D, Sabin C, Pozniak A, Matthias R, Geretti AM, Clarke J, Churchill D, Williams I, Hill T, Green H, Porter K, Scullard G, Johnson M, Easterbrook P, Gilson R, Fisher M, Loveday C, Gazzard B, Pillay D; UK Collaborative Group on HIV Drug Resistance; UK CHIC Study Group.

AIDS. 2005 Mar 25;19(5):487-94.


Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.

Novak RM, Chen L, MacArthur RD, Baxter JD, Huppler Hullsiek K, Peng G, Xiang Y, Henely C, Schmetter B, Uy J, van den Berg-Wolf M, Kozal M; Terry Beirn Community Programs for Clinical Research on AIDS 058 Study Team.

Clin Infect Dis. 2005 Feb 1;40(3):468-74. Epub 2005 Jan 10.


Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.

Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, Brumme CJ, Brumme ZL, Mo T, Alexander CS, Montaner JS.

J Infect Dis. 2005 Feb 1;191(3):339-47. Epub 2004 Dec 22.


Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy.

Nettles RE, Kieffer TL, Simmons RP, Cofrancesco J Jr, Moore RD, Gallant JE, Persaud D, Siliciano RF.

Clin Infect Dis. 2004 Oct 1;39(7):1030-7. Epub 2004 Sep 1.


Prevalence of antiretroviral drug resistance in the HIV-1-infected urban indigent population in San Francisco: a representative study.

Holodniy M, Charlebois ED, Bangsberg DR, Zolopa AR, Schulte M, Moss AR.

Int J STD AIDS. 2004 Aug;15(8):543-51.


Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.

Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK; 903 Study Group.

JAMA. 2004 Jul 14;292(2):191-201.


Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001.

Violin M, Velleca R, Cozzi-Lepri A, Riva C, Grossi PA, Carnevale G, Rizzardini G, Petrelli E, Perno CF, Monforte Ad, Balotta C; ICoNA Study Group.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):761-4. No abstract available.


HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization.

Kagan R, Winters M, Merigan T, Heseltine P.

AIDS Res Hum Retroviruses. 2004 Jan;20(1):1-9.


Antiretroviral-drug resistance among patients recently infected with HIV.

Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD.

N Engl J Med. 2002 Aug 8;347(6):385-94.


Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy.

Baxter JD, Merigan TC, Wentworth DN, Neaton JD, Hoover ML, Hoetelmans RM, Piscitelli SC, Verbiest WH, Mayers DL; CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

AIDS. 2002 May 24;16(8):1131-8.


Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.

Harzic M, Pellegrin I, Deveau C, Chaix ML, Dubeaux B, Garrigue I, Ngo N, Rouzioux C, Goujard C, Hoen B, Sereni D, Delfraissy JF, Meyer L; PRIMO Study Group.

AIDS. 2002 Mar 29;16(5):793-6. No abstract available.


Participation in clinical studies among patients infected with HIV-1 in a single treatment centre over 12 years.

Madge S, Mocroft A, Wilson D, Youle M, Lipman MC, Phillips A, Tyrer M, Cozzi-Lepri A, Swaden L, Johnson MA.

HIV Med. 2000 Oct;1(4):212-8.


Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples.

Hertogs K, Bloor S, Kemp SD, Van den Eynde C, Alcorn TM, Pauwels R, Van Houtte M, Staszewski S, Miller V, Larder BA.

AIDS. 2000 Jun 16;14(9):1203-10.


Supplemental Content

Support Center